CSIMarket
Amgen Inc   (AMGN)
Other Ticker:  
 
 
 

Competition by AMGN's Divisions

(Most recent Quarter in Millions of $)



COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN EPOGEN TM 978.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Eli Lilly And Company LLY Cardiovascular 759.9 0.0 -
Merck and Co Inc MRK Zetia 633.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
APROX. MARKET   SUBTOTAL 15,992 177 1.11 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Aranesp TM-U.S. 215.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Bristol Myers Squibb Co BMY Other 1,842.0 0.0 -
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Eli Lilly And Company LLY Cardiovascular 759.9 0.0 -
Merck and Co Inc MRK Zetia 633.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
APROX. MARKET   SUBTOTAL 17,071 177 1.04 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Aranesp TM-International 321.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Bristol Myers Squibb Co BMY Other 1,842.0 0.0 -
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Eli Lilly And Company LLY Cardiovascular 759.9 0.0 -
Merck and Co Inc MRK Zetia 633.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
APROX. MARKET   SUBTOTAL 17,177 177 1.03 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN NEUPOGEN TM-U.S. 268.0 0.0 -
Alexion Pharmaceuticals Inc ALXN Total 1,636.5 489.2 29.89 %
Biogen Inc BIIB AVONEX 615.2 0.0 -
Biogen Inc BIIB TYSABRI 463.1 0.0 -
Bristol Myers Squibb Co BMY SPRYCEL 411.0 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Merck and Co Inc MRK Remicade 442.0 0.0 -
Pfizer Inc PFE All other 9,146.0 0.0 -
Pfizer Inc PFE Other 345.0 3,917.0 1135.36 %
APROX. MARKET   SUBTOTAL 13,872 4,406 31.76 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN NEUPOGEN TM-International 64.0 0.0 -
Alexion Pharmaceuticals Inc ALXN Total 1,636.5 489.2 29.89 %
Biogen Inc BIIB AVONEX 615.2 0.0 -
Biogen Inc BIIB TYSABRI 463.1 0.0 -
Bristol Myers Squibb Co BMY SPRYCEL 411.0 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Johnson and Johnson JNJ Other 1,615.0 0.0 -
Merck and Co Inc MRK Remicade 442.0 0.0 -
Pfizer Inc PFE All other 9,146.0 0.0 -
Pfizer Inc PFE Other 345.0 3,917.0 1135.36 %
APROX. MARKET   SUBTOTAL 15,283 4,406 28.83 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN NeulastaTM-U.S. 794.0 0.0 -
Johnson and Johnson JNJ Other 1,615.0 0.0 -
Pfizer Inc PFE Urology 333.0 0.0 -
APROX. MARKET   SUBTOTAL 2,742 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN NeulastaTM-International 285.0 0.0 -
Johnson and Johnson JNJ Other 1,615.0 0.0 -
Pfizer Inc PFE Urology 333.0 0.0 -
APROX. MARKET   SUBTOTAL 2,233 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN ENBREL TM-U.S. 991.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Biogen Inc BIIB AVONEX 615.2 0.0 -
Biogen Inc BIIB TYSABRI 463.1 0.0 -
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Merck and Co Inc MRK Remicade 442.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE Other 345.0 3,917.0 1135.36 %
APROX. MARKET   SUBTOTAL 14,109 4,094 29.02 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN ENBREL TM-International 67.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Biogen Inc BIIB AVONEX 615.2 0.0 -
Biogen Inc BIIB TYSABRI 463.1 0.0 -
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Merck and Co Inc MRK Remicade 442.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
Pfizer Inc PFE Other 345.0 3,917.0 1135.36 %
APROX. MARKET   SUBTOTAL 15,009 4,094 27.28 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Other product sales 0.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Bristol Myers Squibb Co BMY Other 1,842.0 0.0 -
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Bristol Myers Squibb Co BMY Eliquis 466.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Eli Lilly And Company LLY Endocrinology 1,786.4 0.0 -
Merck and Co Inc MRK Zocor 56.0 0.0 -
Merck and Co Inc MRK CozaarHyzaar 150.0 0.0 -
Merck and Co Inc MRK Januvia 1,014.0 0.0 -
Mylan N v MYL Total 2,972.1 185.7 6.25 %
Pfizer Inc PFE Cardiovascular metabolic diseases 3,233.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE Other 345.0 3,917.0 1135.36 %
Pfizer Inc PFE Cardiovascular & metabolic diseases 959.0 0.0 -
APROX. MARKET   SUBTOTAL 24,077 4,280 17.78 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Vectibix 54.0 0.0 -
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Merck and Co Inc MRK Other 5,797.0 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
APROX. MARKET   SUBTOTAL 7,674 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Sensipar TM 0.0 0.0 -
Bristol Myers Squibb Co BMY SPRYCEL 411.0 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Eli Lilly And Company LLY Cardiovascular 759.9 0.0 -
Merck and Co Inc MRK Zetia 633.0 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
APROX. MARKET   SUBTOTAL 4,172 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Aranesp 493.0 0.0 -
APROX. MARKET   SUBTOTAL 493 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Prolia 640.0 0.0 -
Merck and Co Inc MRK Fosamax 285.0 0.0 -
APROX. MARKET   SUBTOTAL 925 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN Neulasta 2,323.0 0.0 -
APROX. MARKET   SUBTOTAL 2,323 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Amgen Inc AMGN ENBREL 1,459.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Biogen Inc BIIB AVONEX 615.2 0.0 -
Biogen Inc BIIB TYSABRI 463.1 0.0 -
Biogen Inc BIIB TECFIDERA 883.3 0.0 -
Biogen Inc BIIB PLEGRIDY 74.5 0.0 -
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Merck and Co Inc MRK Remicade 442.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Pfizer Inc PFE All other 9,146.0 0.0 -
Pfizer Inc PFE Other 345.0 3,917.0 1135.36 %
APROX. MARKET   SUBTOTAL 24,681 4,094 16.59 %





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UPDC's Profile

Stock Price

UPDC's Financials

Business Description

Fundamentals

Charts & Quotes

UPDC's News

Suppliers

UPDC's Competitors

Customers & Markets

Economic Indicators

UPDC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071